Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $546.6500 (-3.91%) ($546.0101 - $567.8600) on Thu. Aug. 20, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.53% (three month average) | RSI | 51 | Latest Price | $546.6500(-3.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(66%) XLV(54%) XBI(51%) QQQ(43%) SPY(42%) | Factors Impacting REGN price | REGN will decline at least -6.265% in a week (0% probabilities). VIXM(-17%) TLT(-10%) UUP(-5%) SHY(-4%) TIP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.265% (StdDev 12.53%) | Hourly BBV | 0 () | Intraday Trend | -2.6% | | | |
|
Resistance Level | $566.01 | 5 Day Moving Average | $567.66(-3.7%) | 10 Day Moving Average | $571.46(-4.34%) | 20 Day Moving Average | $566.01(-3.42%) | To recent high | -7.7% | To recent low | 11% | Market Cap | $57.961b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |